COMMUNIQUÉS West-GlobeNewswire

Fangzhou Showcases Award-Winning AI Chronic Care Solution at Fortune China 500 Forum
23/10/2026
CHENGDU, China, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, was invited to showcase its “AI + Chronic [...]
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
23/10/2026
MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore is presenting virtually at the Emerging Growth [...]
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
23/10/2026
In the large, pivotal Phase 3 Launch-HTN trial, lorundrostat achieved similar significant blood pressure reductions in participants with and without CKD, with consistent reductions across Stages 1-3 CKD In participants [...]
Le KFSH renforce ses capacités de prise en charge des soins complexes en repensant le parcours des patients aux urgences
23/10/2026
RIYADH, Arabie saoudite, 23 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a renforcé sa capacité de prise en charge des soins complexes en repensant le parcours des patients [...]
Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering
23/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics [...]
Orange Hospice Receives BusinessRate Best of 2026 Award as a Hospice in Orange County
23/10/2026
Buena Park recognition reflects more than 40 five-star family reviews as the provider marks five years of hospice care in Orange County. Buena Park, CA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Orange Hospice has received [...]
Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026
22/10/2026
LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 27, 2026 at 8:30 a.m. Eastern [...]
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
22/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September [...]
Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
22/10/2026
WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026
22/10/2026
BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2026 [...]
Ligand to Host Investor Day on December 8, 2026
22/10/2026
JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m [...]
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
22/10/2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release [...]
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
22/10/2026
Annualized eGFR slope of -0.6 vs. -5.7 mL/min/1.73 m²/year for placebo, a 5.1 mL/min/1.73 m²/year treatment difference (p<0.001) 89% and 81% reductions in risk of confirmed ≥30% and ≥40% eGFR declines, respectively [...]
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
22/10/2026
Clinical development of ARD-101 for hyperphagia in Prader-Willi Syndrome (PWS) may resume Aardvark will host a webcast to review available dataset from the terminated Phase 3 HERO trial and OLE trial on Friday, October [...]
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
22/10/2026
Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia Highlights Collaboration aims to accelerate precision oncology research in Australia Combines Fortrea’s [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/10/2026
WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
22/10/2026
GAITHERSBURG, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its third quarter 2026 [...]
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
22/10/2026
Patient advocacy initiative expands its reach with a nationally recognized voice on health, resilience and informed treatment decisions TORONTO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX [...]
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
22/10/2026
Publication marks a milestone for VisONE™ cardiac diaphragm support as enrollment continues in the RECOVER-HF pivotal IDE trial PORTLAND, Ore., Oct. 22, 2026 (GLOBE NEWSWIRE) -- VisCardia, Inc. today announced the [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum